 |
| |
 Printable version |
Dronedarone: FDA Drug Safety Communication |
Médecine. Volume 7, Number 1, 17-9, Janvier 2011, Thérapeutiques
|
 Résumé
Article gratuit
|
Author(s) : Jean-Pierre Vallée |
Summary : [1-14-2011] The US Food and Drug Administration (FDA) is alerting healthcare professionals and patients about cases of rare, but severe liver injury, including two cases of acute liver failure leading to liver transplant in patients treated with the heart medication dronedarone (Multaq). |
Keywords : anti-arythmia agents, atrial fibrillation, hepatitis, drug toxicity |
